<!DOCTYPE html>

<html lang="en" data-theme="light">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Adrenergic Transmission & Drugs - Essentials of Medical Pharmacology</title>

<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">

<link rel="stylesheet" href="../styles/main.css">

<script>
MathJax = {
    tex: {
        inlineMath: [['$', '$'], ['\\(', '\\)']],
        displayMath: [['$$', '$$'], ['\\[', '\\]']],
        processEscapes: true,
        processEnvironments: true
    },
    svg: { fontCache: 'global' },
    options: {
        skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
    }
};
</script>
<script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
<a href="#main-content" class="skip-link">Skip to main content</a>

<button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
    <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
    <span class="theme-toggle-icon dark-icon">üåô</span>
</button>

<div class="reading-progress-container">
    <div class="reading-progress-bar" id="reading-progress"></div>
</div>

<!-- Floating TOC -->
<nav class="floating-toc" id="floating-toc">
    <div class="floating-toc-header">
        <span>üìë</span> Table of Contents
    </div>
    <ul class="floating-toc-list">
        <li><a href="#transmission">Adrenergic Transmission</a></li>
        <li><a href="#receptors">Adrenergic Receptors</a></li>
        <li><a href="#drugs-classification">Adrenergic Drugs</a></li>
        <li><a href="#catecholamines">Catecholamines</a></li>
        <li><a href="#non-catecholamines">Non-Catecholamines</a></li>
        <li><a href="#uses">Therapeutic Uses</a></li>
        <li><a href="#problem-study">Problem Directed Study</a></li>
    </ul>
</nav>

<div class="page-wrapper">
    <div class="container">
        <article class="document-article">
            <header class="document-header">
                <div class="header-badge">
                    <span>‚ö°</span>
                    <span>Topic 10</span>
                </div>
                <h1 class="document-title">Adrenergic Transmission and Adrenergic Drugs</h1>
                <div class="title-meta">
                    <div class="meta-item">
                        <span>üìö</span>
                        <span>Drugs Acting on ANS</span>
                    </div>
                    <div class="meta-item">
                        <span>‚è±Ô∏è</span>
                        <span>45 min read</span>
                    </div>
                </div>
            </header>

            <main id="main-content" class="content-wrapper">
                <!-- Section 1: Transmission -->
                <section class="content-section" id="transmission">
                    <div class="section-header">
                        <div class="section-number">01</div>
                        <h2 class="section-title">
                            <span class="title-icon">üîå</span>
                            Adrenergic Transmission
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Adrenergic transmission is restricted to the sympathetic division of the ANS. There are three closely related endogenous catecholamines (CAs) which act as signal molecules:</p>
                        <ul>
                            <li><strong>Noradrenaline (NA):</strong> Transmitter at postganglionic sympathetic sites and in brain.</li>
                            <li><strong>Adrenaline (Adr):</strong> Major hormone secreted by adrenal medulla.</li>
                            <li><strong>Dopamine (DA):</strong> Major transmitter in basal ganglia, limbic system, anterior pituitary, etc.</li>
                        </ul>

                        <h3>Synthesis of Catecholamines</h3>
                        <p><strong>Biosynthesis pathway:</strong><br>
                        Phenylalanine $\xrightarrow{\text{Hydroxylase}}$ Tyrosine $\xrightarrow{\text{Tyrosine hydroxylase}}$ Dopa $\xrightarrow{\text{Dopa decarboxylase}}$ Dopamine $\xrightarrow{\text{Dopamine } \beta \text{-hydroxylase}}$ Noradrenaline $\xrightarrow{\text{PNMT}}$ Adrenaline</p>
                        <p><strong>Rate limiting step:</strong> Tyrosine hydroxylase (inhibited by $\alpha$-methyl-p-tyrosine).</p>

                        <h3>Storage, Release and Uptake</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker"></span>
                                <span class="list-content"><strong>Storage:</strong> NA is stored in synaptic vesicles complexed with ATP and chromogranin. Transport into vesicles is by <strong>VMAT-2</strong> (Inhibited by Reserpine).</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker"></span>
                                <span class="list-content"><strong>Release:</strong> Occurs by exocytosis. Modulated by presynaptic receptors ($\alpha_2$ inhibits, $\beta_2$ enhances).</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker"></span>
                                <span class="list-content"><strong>Reuptake (Termination):</strong>
                                    <ul>
                                        <li><strong>Axonal Uptake (Uptake-1):</strong> Active transport by <strong>NET</strong>. Most important mechanism for terminating action. Inhibited by cocaine, desipramine.</li>
                                        <li><strong>Extraneuronal Uptake (Uptake-2):</strong> Transport into other tissues. Minor importance.</li>
                                    </ul>
                                </span>
                            </li>
                        </ul>

                        <h3>Metabolism</h3>
                        <p>The major enzymes involved are <strong>Monoamine oxidase (MAO)</strong> and <strong>Catechol-O-methyl transferase (COMT)</strong>. Major metabolites excreted in urine are VMA (vanillylmandelic acid) and MOPEG.</p>
                        
                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../../../../../assets/images/image-20251214-6e1281dc.jpeg" alt="Metabolism of catecholamines" class="figure-image">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 9.2: Metabolism of catecholamines</figcaption>
                        </figure>
                    </div>
                </section>

                <!-- Section 2: Receptors -->
                <section class="content-section" id="receptors">
                    <div class="section-header">
                        <div class="section-number">02</div>
                        <h2 class="section-title">
                            <span class="title-icon">üì°</span>
                            Adrenergic Receptors
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Adrenergic receptors are G-protein coupled receptors classified into $\alpha$ and $\beta$ types.</p>

                        <div class="table-responsive">
                            <table class="comparison-table">
                                <thead>
                                    <tr>
                                        <th>Type</th>
                                        <th>Subtypes</th>
                                        <th>Mechanism</th>
                                        <th>Key Functions</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>$\alpha$ (Alpha)</strong></td>
                                        <td>$\alpha_1$</td>
                                        <td>Gq $\rightarrow$ $\uparrow$ IP3/DAG $\rightarrow$ $\uparrow$ Ca$^{2+}$</td>
                                        <td>Vasoconstriction, Mydriasis, Gut relaxation, Contraction of genitourinary smooth muscle.</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>$\alpha_2$</td>
                                        <td>Gi $\rightarrow$ $\downarrow$ cAMP</td>
                                        <td>Inhibition of transmitter release (presynaptic), Vasoconstriction, $\downarrow$ Insulin release.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>$\beta$ (Beta)</strong></td>
                                        <td>$\beta_1$</td>
                                        <td>Gs $\rightarrow$ $\uparrow$ cAMP</td>
                                        <td><strong>Cardiac stimulation</strong> ($\uparrow$ Rate, Force, Conduction), Renin release.</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>$\beta_2$</td>
                                        <td>Gs $\rightarrow$ $\uparrow$ cAMP</td>
                                        <td><strong>Bronchodilatation</strong>, Vasodilatation, Uterine relaxation, Glycogenolysis.</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>$\beta_3$</td>
                                        <td>Gs $\rightarrow$ $\uparrow$ cAMP</td>
                                        <td>Lipolysis, Detrusor relaxation.</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        
                        <p><strong>Rank order of potency of agonists:</strong></p>
                        <ul>
                            <li>$\alpha$ receptors: Adr > NA > Isoprenaline</li>
                            <li>$\beta$ receptors: Isoprenaline > Adr > NA</li>
                        </ul>
                    </div>
                </section>

                <!-- Section 3: Drugs Classification -->
                <section class="content-section" id="drugs-classification">
                    <div class="section-header">
                        <div class="section-number">03</div>
                        <h2 class="section-title">
                            <span class="title-icon">üíä</span>
                            Adrenergic Drugs (Sympathomimetics)
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>These drugs mimic the actions of sympathetic stimulation. They are classified based on mode of action:</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><strong>Direct sympathomimetics:</strong> Act directly as agonists on $\alpha$ or $\beta$ receptors (e.g., Adr, NA, Isoprenaline, Phenylephrine, Salbutamol).</li>
                            <li class="list-item"><strong>Indirect sympathomimetics:</strong> Act on adrenergic neurone to release NA (e.g., Tyramine, Amphetamine).</li>
                            <li class="list-item"><strong>Mixed action sympathomimetics:</strong> Act directly as well as indirectly (e.g., Ephedrine, Mephentermine).</li>
                        </ul>
                    </div>
                </section>

                <!-- Section 4: Catecholamines -->
                <section class="content-section" id="catecholamines">
                    <div class="section-header">
                        <div class="section-number">04</div>
                        <h2 class="section-title">
                            <span class="title-icon">üß™</span>
                            Catecholamines
                        </h2>
                    </div>

                    <div class="content-card">
                        <h3>1. Adrenaline (Epinephrine)</h3>
                        <p>Potent stimulant of both $\alpha$ and $\beta$ receptors.</p>
                        <ul>
                            <li><strong>Heart ($\beta_1$):</strong> Increases rate, force, cardiac output and oxygen consumption.</li>
                            <li><strong>Blood vessels:</strong> Constricts skin/mucous membrane vessels ($\alpha_1$); dilates skeletal muscle vessels ($\beta_2$). Low doses fall BP (vasodilation dominates), high doses rise BP.</li>
                            <li><strong>Respiration ($\beta_2$):</strong> Powerful bronchodilatation.</li>
                            <li><strong>Metabolism:</strong> Hyperglycaemia (glycogenolysis), Lipolysis.</li>
                        </ul>
                        <p><strong>Uses:</strong> Anaphylactic shock (Drug of choice, 0.5 mg i.m.), Cardiac arrest, with Local anaesthetics (prolongs action), Control of local bleeding.</p>

                        <h3>2. Noradrenaline (Norepinephrine)</h3>
                        <p>Predominantly acts on $\alpha$ receptors and $\beta_1$ receptors (Little action on $\beta_2$).</p>
                        <ul>
                            <li>Causes generalized vasoconstriction ($\alpha$) $\rightarrow$ Systolic, Diastolic and Mean BP rise.</li>
                            <li>Reflex bradycardia occurs (due to rise in BP).</li>
                            <li><strong>Use:</strong> As pressor agent in shock (rarely used now, Dopamine/Dobutamine preferred). Administered only by slow i.v. infusion ($2-4 \mu \text{g/min}$).</li>
                        </ul>

                        <h3>3. Isoprenaline</h3>
                        <p>Potent non-selective $\beta$ agonist ($\beta_1 + \beta_2$). No $\alpha$ action.</p>
                        <ul>
                            <li><strong>Heart:</strong> Marked tachycardia, increased contractility.</li>
                            <li><strong>BP:</strong> Systolic may rise, but Diastolic falls sharply (vasodilation). Mean BP falls.</li>
                            <li><strong>Use:</strong> Heart block, Cardiac arrest (temporary measure).</li>
                        </ul>

                        <h3>4. Dopamine</h3>
                        <p>Agonist at D1, D2, $\beta_1$ and (at high doses) $\alpha$ receptors.</p>
                        <ul>
                            <li><strong>Low dose:</strong> Dilates renal/mesenteric vessels (D1) $\rightarrow$ Increases GFR, Na+ excretion.</li>
                            <li><strong>Moderate dose:</strong> Positive inotropic effect ($\beta_1$).</li>
                            <li><strong>High dose:</strong> Vasoconstriction ($\alpha_1$).</li>
                            <li><strong>Use:</strong> Cardiogenic or septic shock ($0.2-1 \text{ mg/min}$ i.v. infusion).</li>
                        </ul>

                        <h3>5. Dobutamine</h3>
                        <p>Derivative of Dopamine. Relatively selective $\beta_1$ agonist.</p>
                        <ul>
                            <li>Increases force of contraction with less effect on heart rate than Isoprenaline.</li>
                            <li><strong>Use:</strong> Inotropic agent in pump failure, MI, CHF ($2-8 \mu \text{g/kg/min}$ i.v. infusion).</li>
                        </ul>
                        
                        <div class="table-responsive">
                            <table class="comparison-table">
                                <thead>
                                    <tr>
                                        <th>Drug</th>
                                        <th>Receptor Profile</th>
                                        <th>Main Effect</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Adrenaline</strong></td>
                                        <td>$\alpha_1, \alpha_2, \beta_1, \beta_2$</td>
                                        <td>Cardiac stimulation, Bronchodilatation, Vasoconstriction/dilatation</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Noradrenaline</strong></td>
                                        <td>$\alpha_1, \alpha_2, \beta_1$</td>
                                        <td>Vasoconstriction, BP rise</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Isoprenaline</strong></td>
                                        <td>$\beta_1, \beta_2$</td>
                                        <td>Cardiac stimulation, Vasodilatation, Bronchodilatation</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Dopamine</strong></td>
                                        <td>D1, D2, $\beta_1, \alpha$</td>
                                        <td>Renal vasodilatation, Cardiac stimulation</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Dobutamine</strong></td>
                                        <td>$\beta_1$</td>
                                        <td>Positive inotropic</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>

                <!-- Section 5: Non-Catecholamines -->
                <section class="content-section" id="non-catecholamines">
                    <div class="section-header">
                        <div class="section-number">05</div>
                        <h2 class="section-title">
                            <span class="title-icon">üíä</span>
                            Non-Catecholamines
                        </h2>
                    </div>

                    <div class="content-card">
                        <h3>Ephedrine</h3>
                        <p>Alkaloid from <em>Ephedra vulgaris</em>. Mixed action (direct + indirect). Orally active, crosses BBB (CNS stimulation). Resistant to MAO. Longer acting than Adr. Used in mild asthma, hypotension.</p>

                        <h3>Amphetamines</h3>
                        <p>Synthetic. Potent CNS stimulant. Indirectly releases NA and DA. Orally active. High abuse potential. Used in Narcolepsy and ADHD (Alternatives preferred).</p>

                        <h3>Phenylephrine</h3>
                        <p>Selective $\alpha_1$ agonist. Raises BP, causes reflex bradycardia. Used as nasal decongestant, mydriatic, and pressor agent.</p>

                        <h3>Nasal Decongestants</h3>
                        <p><strong>Xylometazoline, Oxymetazoline:</strong> $\alpha$-agonists (imidazoline compounds). Topical application produces vasoconstriction in nasal mucosa. Long acting (12 hrs). Side effects: Atrophic rhinitis on prolonged use.</p>

                        <h3>Selective $\beta_2$ Stimulants</h3>
                        <p><strong>Salbutamol, Terbutaline:</strong> Bronchodilatation, Uterine relaxation. Less cardiac stimulation. <strong>Use:</strong> Bronchial asthma, Premature labour.</p>
                        
                        <div class="callout callout--note">
                            <div class="callout-header">
                                <span class="callout-icon">üí°</span>
                                <h4 class="callout-title">Other Specific Agents</h4>
                            </div>
                            <div class="callout-content">
                                <ul>
                                    <li><strong>Isoxsuprine:</strong> $\beta$ receptor stimulant, vasodilator, uterine relaxant. Used in threatened abortion (doubtful efficacy), peripheral vascular diseases.</li>
                                    <li><strong>Ritodrine:</strong> Selective $\beta_2$ agonist used as uterine relaxant to postpone labour.</li>
                                    <li><strong>Mirabegron:</strong> Selective $\beta_3$ agonist. Relaxes detrusor muscle. Used in overactive bladder.</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </section>

                <!-- Section 6: Therapeutic Uses -->
                <section class="content-section" id="uses">
                    <div class="section-header">
                        <div class="section-number">06</div>
                        <h2 class="section-title">
                            <span class="title-icon">üíâ</span>
                            Therapeutic Uses
                        </h2>
                    </div>

                    <div class="content-card">
                        <h4>1. Vascular Uses</h4>
                        <ul>
                            <li><strong>Anaphylactic shock:</strong> Adrenaline (0.5 mg i.m.) is life saving.</li>
                            <li><strong>Hypotension (Shock):</strong> Dopamine, Noradrenaline (as pressor agents).</li>
                            <li><strong>Local haemostasis:</strong> Adrenaline pack for epistaxis.</li>
                            <li><strong>With Local Anaesthetics:</strong> Adrenaline (1:200,000) prolongs duration.</li>
                            <li><strong>Nasal Decongestion:</strong> Xylometazoline, Phenylephrine drops.</li>
                        </ul>

                        <h4>2. Cardiac Uses</h4>
                        <ul>
                            <li><strong>Cardiac Arrest:</strong> Adrenaline (i.v./intracardiac).</li>
                            <li><strong>Heart Block:</strong> Isoprenaline.</li>
                            <li><strong>Congestive Heart Failure:</strong> Dopamine / Dobutamine (short term inotropic support).</li>
                        </ul>

                        <h4>3. Respiratory</h4>
                        <p><strong>Bronchial Asthma / COPD:</strong> Selective $\beta_2$ agonists (Salbutamol, Salmeterol) are primary drugs.</p>

                        <h4>4. Ocular</h4>
                        <p><strong>Glaucoma:</strong> Dipivefrine (prodrug of Adr), Apraclonidine, Brimonidine ($\alpha_2$ agonists) reduce aqueous formation.</p>
                        <p><strong>Mydriatic:</strong> Phenylephrine (without cycloplegia) for fundoscopy.</p>

                        <h4>5. Central Uses</h4>
                        <p><strong>ADHD, Narcolepsy:</strong> Amphetamines (Methylphenidate, Modafinil now preferred).</p>

                        <h4>6. Uterine Relaxant (Tocolytic)</h4>
                        <p>Ritodrine, Isoxsuprine to delay premature labour.</p>
                    </div>
                </section>

                <!-- Problem Directed Study -->
                <section class="content-section" id="problem-study">
                    <div class="section-header">
                        <div class="section-number">07</div>
                        <h2 class="section-title">
                            <span class="title-icon">üß©</span>
                            Problem Directed Study
                        </h2>
                    </div>

                    <div class="content-card">
                        <div class="callout callout--warning">
                            <div class="callout-header">
                                <span class="callout-icon">‚ùì</span>
                                <h4 class="callout-title">Case Study 9.1</h4>
                            </div>
                            <div class="callout-content">
                                <p>A lady aged 55 years presented for eye checkup. She has been having visual difficulty over the past few months, and lately she had started noticing 'halos' around the lights. She also has dull chronic ache in the forehead region. Tonometry revealed her intraocular pressure (i.o.p.) to be 22 and 24 mm Hg respectively in the left and right eye.</p>
                                <p><strong>(a) Which mydriatic will be suitable for dilating her pupil for fundus examination and why?</strong></p>
                                <p><em>(See Appendix-1 for solution)</em></p>
                            </div>
                        </div>
                    </div>
                </section>

            </main>

            <nav class="document-nav">
                <div class="nav-container">
                    <a href="topic-09-anticholinergic.html" class="nav-button nav-button--large nav-button--previous">
                        <div class="nav-label">Previous</div>
                        <div class="nav-title">Anticholinergic Drugs</div>
                    </a>
                    
                    <div class="document-progress">
                        <div class="progress-indicator">
                            <span>10</span>
                            <span class="progress-separator">/</span>
                            <span>13</span>
                        </div>
                        <div class="progress-bar-container">
                            <div class="progress-bar-fill" style="width: 76.9%;"></div>
                        </div>
                        <div class="progress-label">Topic Progress</div>
                    </div>
                    
                    <a href="topic-11-antiadrenergic.html" class="nav-button nav-button--large nav-button--next">
                        <div class="nav-label">Next</div>
                        <div class="nav-title">Antiadrenergic Drugs</div>
                    </a>
                </div>
            </nav>
        </article>
    </div>
</div>

<!-- Lightbox Modal -->
<div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
    <div class="lightbox-backdrop"></div>
    <div class="lightbox-content">
        <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
        <img class="lightbox-image" src="" alt="">
        <p class="lightbox-caption"></p>
    </div>
</div>

<script src="../js/theme.js"></script>
<script src="../js/navigation.js"></script>
<script src="../js/interactions.js"></script>
</body>
</html>
